<?xml version="1.0" encoding="UTF-8"?>
<ref id="B59-vaccines-07-00168">
 <label>59.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Principi</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Di Cara</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Bizzarri</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Isidori</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Borgia</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mignini</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Saponara</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Argentiero</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Esposito</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Prevention of Invasive Pneumococcal Disease: Problems Emerged after Some Years of the 13-Valent Pneumococcal Conjugate Vaccine Use</article-title>
  <source>Curr. Infect. Dis. Rep.</source>
  <year>2018</year>
  <volume>20</volume>
  <fpage>1</fpage>
  <pub-id pub-id-type="doi">10.1007/s11908-018-0607-z</pub-id>
  <pub-id pub-id-type="pmid">29368250</pub-id>
 </element-citation>
</ref>
